4.2 Review

Risk of additional cancers in untreated and treated hairy cell leukemia patients

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice

Constantin A. Dasanu

EXPERT OPINION ON PHARMACOTHERAPY (2008)

Article Hematology

A population-based study of hairy cell leukemia in Israel

Ora Paltiel et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2006)

Article Hematology

Concomitant hairy cell and acute myeloid leukemia

T Rimner et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2006)

Review Pharmacology & Pharmacy

Pentostatin - pharmacology, immunology, and clinical effects in graft-versus-host disease

M Higman et al.

EXPERT OPINION ON PHARMACOTHERAPY (2004)

Article Hematology

Clinical manifestations and infectious complications of hairy-cell leukaemia

EH Kraut

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2003)

Article Oncology

Extended follow-up of patients with hairy cell leukemia after treatment with cladribine

GR Goodman et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

Article Hematology

Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues

CR Larsen et al.

AMERICAN JOURNAL OF HEMATOLOGY (2002)

Article Oncology

Risk of second cancer in patients with Hairy Cell Leukemia:: Long-term follow-up

M Federico et al.

JOURNAL OF CLINICAL ONCOLOGY (2002)

Article Hematology

Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia

A Bourguin-Plonquet et al.

BRITISH JOURNAL OF HAEMATOLOGY (2002)